These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 7864704)

  • 21. Comparison of once-daily extended-release ciprofloxacin and conventional twice-daily ciprofloxacin for the treatment of uncomplicated urinary tract infection in women.
    Henry DC; Bettis RB; Riffer E; Haverstock DC; Kowalsky SF; Manning K; Hamed KA; Church DA
    Clin Ther; 2002 Dec; 24(12):2088-104. PubMed ID: 12581547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rufloxacin once daily versus ciprofloxacin twice daily in the treatment of patients with acute uncomplicated pyelonephritis.
    Bach D; van den Berg-Segers A; Hübner A; van Breukelen G; Cesana M; Plétan Y
    J Urol; 1995 Jul; 154(1):19-24. PubMed ID: 7776420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Five-day therapy with cephradine capsules, 500 mg BID, for the treatment of acute, uncomplicated urinary tract infections.
    Brosof AB
    Clin Ther; 1980; 3(4):285-91. PubMed ID: 7023676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multicenter comparative trial of three-day norfloxacin vs ten-day sulfamethoxazole and trimethoprim for the treatment of uncomplicated urinary tract infections.
    Stein GE; Mummaw N; Goldstein EJ; Boyko EJ; Reller LB; Kurtz TO; Miller K; Cox CE
    Arch Intern Med; 1987 Oct; 147(10):1760-2. PubMed ID: 3310941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fleroxacin versus norfloxacin in the treatment of urinary tract infections: a multicenter, double-blind, prospective, randomized, comparative study.
    Pummer K
    Am J Med; 1993 Mar; 94(3A):108S-113S. PubMed ID: 8452165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized double-blind trial of high- and low-dose fleroxacin versus norfloxacin for complicated urinary tract infection.
    Pittman W; Moon JO; Hamrick LC; Cox CE; Clark J; Childs S; Pizzuti D; Fredericks J; St Clair P
    Am J Med; 1993 Mar; 94(3A):101S-104S. PubMed ID: 8452163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal duration of antibiotic therapy for uncomplicated urinary tract infection in older women: a double-blind randomized controlled trial.
    Vogel T; Verreault R; Gourdeau M; Morin M; Grenier-Gosselin L; Rochette L
    CMAJ; 2004 Feb; 170(4):469-73. PubMed ID: 14970093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ciprofloxacin: an update on clinical experience.
    Arcieri G; Griffith E; Gruenwaldt G; Heyd A; O'Brien B; Becker N; August R
    Am J Med; 1987 Apr; 82(4A):381-6. PubMed ID: 3555063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fleroxacin versus norfloxacin for oral treatment of serious urinary tract infections.
    Childs SJ
    Am J Med; 1993 Mar; 94(3A):105S-107S. PubMed ID: 8452164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized double-blind comparison of moxifloxacin and doxycycline/metronidazole/ciprofloxacin in the treatment of acute, uncomplicated pelvic inflammatory disease.
    Heystek M; Ross JD;
    Int J STD AIDS; 2009 Oct; 20(10):690-5. PubMed ID: 19815913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of uncomplicated recurrent cystitis in women: lomefloxacin versus norfloxacin].
    Guibert J; Herman H; Capron MH
    Contracept Fertil Sex; 1997 Jan; 25(1):79-84. PubMed ID: 9064058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective, randomized, controlled study comparing two dosing regimens of gentamicin/oral ciprofloxacin switch therapy for acute pyelonephritis.
    Bailey RR; Begg EJ; Smith AH; Robson RA; Lynn KL; Chambers ST; Barclay ML; Hornibrook J
    Clin Nephrol; 1996 Sep; 46(3):183-6. PubMed ID: 8879853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006.
    Peterson J; Kaul S; Khashab M; Fisher A; Kahn JB
    Clin Ther; 2007 Oct; 29(10):2215-21. PubMed ID: 18042477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gatifloxacin 200 mg or 400 mg once daily is as effective as ciprofloxacin 500 mg twice daily for the treatment of patients with acute pyelonephritis or complicated urinary tract infections.
    Naber KG; Bartnicki A; Bischoff W; Hanus M; Milutinovic S; van Belle F; Schönwald S; Weitz P; Ankel-Fuchs D
    Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S41-53. PubMed ID: 15037328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary tract infections with low and high colony counts in young women. Spontaneous remission and single-dose vs multiple-day treatment.
    Arav-Boger R; Leibovici L; Danon YL
    Arch Intern Med; 1994 Feb; 154(3):300-4. PubMed ID: 8297196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ciprofloxacin versus cinoxacin in therapy of urinary tract infections. A randomized, double-blind trial.
    Goldstein EJ; Kahn RM; Alpert ML; Ginsberg BP; Greenway FL; Citron DM
    Am J Med; 1987 Apr; 82(4A):284-7. PubMed ID: 3555049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of fleroxacin and amoxicillin in the treatment of uncomplicated urinary tract infections in women.
    Whitby M; Brown P; Silagy C; Rana C
    Am J Med; 1993 Mar; 94(3A):97S-100S. PubMed ID: 8452191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral ciprofloxacin in the treatment of elderly patients with complicated urinary tract infections due to trimethoprim/sulfamethoxazole-resistant bacteria.
    Preheim LC; Cuevas TA; Roccaforte JS; Mellencamp MA; Bittner MJ
    Am J Med; 1987 Apr; 82(4A):295-300. PubMed ID: 3555051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sequential intravenous/oral ciprofloxacin as an empiric antimicrobial therapy: results of a Canadian multicenter study. The Canadian Collaborative Investigational Group.
    Davis C
    Clin Ther; 1994; 16(3):505-21. PubMed ID: 7923317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
    Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
    J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.